Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: Phenotypes expressed in lung and extrapulmonary macrophages

Infection and Immunity

Volumn 71, Issue 2, 2003, Pages 697-707

  Majorov, Konstantin B ^a   Lyadova, Irina V ^a   Kondratieva, Tatiana K ^a   Eruslanov, Eugeny B ^a   Rubakova, Elvira I ^a   Orlova, Marianna O ^a   Mischenko, Vladimir V ^a   Apt, Alexander S ^a  

^a CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE PROLIFERATION; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; SURVIVAL; TH2 CELL;

ANIMALS; COCULTURE TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; LUNG; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED A; MICE, INBRED STRAINS; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 0037307433     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.2.697-707.2003     Document Type: Article

References (58)

1. Abel, L., F. O. Sanchez, J. Oberti, N. V. Thuc, L. V. Hoa, V. D. Lap, E. Skamene, P. H. Lagrange, and E. Schurr. 1998. Susceptibility to leprosy is linked to the human NRAMP1 gene. J. Infect. Dis. 177:133-145.
2. Altare, F., A. Durandy, D. Lammas, J. F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Doffinger, F. Bernaudin, O. Jeppsson, J. A. Gollob, E. Meinl, A. W. Segal, A. Fischer, D. Kumararatne, and J. L. Casanova. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435.
3. s macrophages correlates with nitric oxide production. J. Infect. Dis. 176:1552-1558.
4. Aston, N., W. N. Rom, A. T. Talbot, and J. Reibman. 1998. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am. J. Respir. Crit. Care Med. 157:1943-1950.
5. Bellamy, R. 1998. Genetic susceptibility to tuberculosis in human populations. Thorax 53:588-593.
6. Bellamy, R., C. Ruwende, T. Corrah, K. McAdam, H. C. Whittle, and A. V. S. Hill. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338:640-644.
7. Bellamy, R., C. Ruwende, T. Corrah, K. P. W. J. McAdams, M. Thursz, H. C. Whittle, and A. V. S. Hill. 1998. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber. Lung Dis. 79:83-89.
8. Bloom, B. R., and C. L. Murray. 1992. Tuberculosis: commentary on a re-emergent killer. Science 257:1055-1064.
9. Bonecini-Almeida, M. G., S. Chitale, I. Boutsikakis, J. Geng, H. Doo, S. He, and J. L. Ho. 1998. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-γ and primed lymphocytes. J. Immunol. 160:4490-4499.
10. Brahmajothi, V., R. M. Pitchappan, V. N. Kakkanaiah, M. Sashidhar, K. Rajaram, S. Ramu, K. Palanimurgan, C. N. Paramasivan, and R. Prabhakar. 1991. Association of pulmonary tuberculosis and HLA in South India. Tubercle 72:123-128.
11. Byrd, T. F. 1998. Multinucleated giant cell formation induced by IFN-gamma/IL-3 is associated with restriction of virulent Mycobacterium tuberculosis cell to cell invasion in human monocyte monolayers. Cell. Immunol. 188:89-96.
12. Chan, J., Y. Xing, R. S. Magliozzo, and B. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
13. Comstock, G. W. 1978. Tuberculosis in twins: a re-analysis of the Prophit survey. Am. Rev. Respir. Dis. 117:621-626.
14. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of intereleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423-432.
15. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffen, D. G. Russel, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:2243-2247.
16. De Jong, R., F. Altare, I. A. Haagen, D. G. Elferink, T. De Boer, P. J. C. van Breda Vriesman, P. J. Kabel, J. M. T. Draaisma, J. T. van Dissel, F. P. Kroon, J. L. Casanova, and T. H. M. Ottenhoff. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-1438.
17. Denis, M. 1991. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin. Exp. Immunol. 84:200-206.
18. Dobos, K. M., E. A. Spotts, F. D. Quinn, and C. H. King. 2000. Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation. Infect. Immun. 68:6300-6310.
19. +, T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 67:3242-3247.
20. Fenton, M. J., and M. W. Vermeulen. 1996. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect. Immun. 64:683-690.
21. Ferrari, G., H. Langen, M. Naito, and J. Pieters. 1999. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97:435-447.
22. Flesch, I., and S. H. E. Kaufmann. 1987. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138:4408-4413.
23. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
24. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
25. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for IFN-γ in resistance to M. tuberculosis infection. J. Exp. Med. 178:2248-2254.
26. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
27. Goldfeld, A. E., J. C. Delgado, S. Thim, M. V. Bozon, A. M. Uglialoro, D. Turbay, C. Cohen, and E. J. Yunis. 1998. Association of HLA-DQ allele with clinical tuberculosis. JAMA 279:226-228.
28. Greenwood, C. M., T. M. Fujiwara, L. J. Boothroyd, M. A. Miller, D. Frappier, et al. 2000. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am. J. Hum. Genet. 67:405-408.
29. Hayashi, T., S. P. Roa, P. R. Meylan, R. S. Kornbluth, and A. Catanzaro. 1999. Role of CD40 ligand in Mycobacterium avium infection. Infect. Immun. 67:3558-3565.
30. Hill, A. V. S. 1996. Genetics of infectious disease resistance. Curt. Opin. Genet. Dev. 6:348-360.
31. Jouanguy, E., F. Altare, S. Lamhamedi, R. Revy, J. F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, and J. L. Casanova. 1996. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-1961.
32. Kramnik, I., W. F. Dietrich, P. Demant, and B. Bloom. 2000. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 97:8560-8565.
33. Lavebratt, C., A. S. Apt, B. V. Nikonenko, M. Schalling, and E. Schurr. 1999. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J. Infect. Dis. 180:150-155.
34. Liu, J., M. Cellier, E. Schurr, and E. Skamene. 1993. Comparative genome analysis - a novel strategy to study the genetics of host-parasite interaction. J. Parasitol. 79:463-470.
35. Lyadova, I. V., E. B. Eruslanov, S. V. Khaidukov, V. V. Yeremeev, K. B. Majorov, A. V. Pichugin, B. V. Nikonenko, T. K. Kondratieva, and A. S. Apt. 2000. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant and hyperresistant to Mycobacterium tuberculosis-triggered disease. J. Immunol. 165:5921-5932.
36. Lyadova, I. V., V. V. Yeremeev, K. B. Majorov, B. V. Nikonenko, S. V. Khaidukov, T. K. Kondratieva, N. V. Kobets, and A. S. Apt. 1998. An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect. Immun. 66:4981-4988.
37. MacMicking, J. D., R. J. North, R. La Course, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
38. McLeod, R., E. Buschman, D. Arbuckle, and E. Skamene. 1995. Immunogenetics in the analysis of resistance to intracellular pathogens. Curr. Opin. Immunol. 7:539-552.
39. Menozzi, F. D., R. Bischoff, E. Fort, M. J. Brennan, and C. Locht. 1998. Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin. Proc. Natl. Acad. Sci. USA 95:12625-12630.
40. Meyer, C. G., J. May, and K. Stark. 1998. Human leukocyte antigens in tuberculosis and leprosy. Trends Microbiol. 6:148-154.
41. Molloy, A., and G. Kaplan. 1996. Cell-mediated immune response in tuberculosis, p. 305-326. In W. N. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown, Boston, Mass.
42. Newport, M., and M. Levin. 1999. Genetic susceptibility to tuberculosis. J. Infect. 39:117-121.
43. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949.
44. Nikonenko, B. V., M. M. Averbakh, C. Lavebratt, E. Schurr, and A. S. Apt. 2000. Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice. Tuber. Lung Dis. 80:15-25.
45. Pospelov, L. E., A. G. Matrakshin, L. N. Chernousova, A. F. Malenko, V. V. Yeremeev, and A. G. Khomenko. 1996. Association of various genetic markers with tuberculosis and other lung diseases in Tuvinian children. Tuber. Lung Dis. 77:77-80.
46. Ratazzi, C., R. D. Arbeit, C. Carini, and H. G. Remold. 1997. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:4320-4327.
47. Rook, G., and R. Hernandez-Pando. 1996. Pathogenesis of tuberculosis. Annu. Rev. Microbiol. 50:259-282.
48. Rose, R. M., J. M. Fuglestad, and L. Remington. 1991. Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma. Am. J. Respir. Cell. Mol. Biol. 4:248-254.
49. Sanchez, F., T. V. Radaeva, B. V. Nikonenko, A.-S. Persson, S. Sengul, M. Schalling, E. Schurr, A. S. Apt, and C. Lavebratt. 2003. Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. Infect. Immun. 71:126-131.
50. Schorey, J. S., M. C. Carroll, and E. J. Brown. 1997. A macrophage invasion mechanism of pathogenic mycobacteria. Science 277:1091-1095.
51. Schuler, N. W., and W. N. Rom. 1998. The host immune response to tuberculosis. Am. J. Respir. Crit. Care Med. 157:679-691.
52. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67:3980-3988.
53. Shaw, M. A., A. Collins, C. S. Peacock, E. N. Miller, G. F. Black, D. Sibthorpe, Z. Lins-Lainson, J. J. Shaw, F. Ramos, F. Silveira, and J. M. Blackwell. 1997. Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligo-genetic control: linkage study of the candidate genes NRAMP1 and TNF-α. Tuber. Lung Dis. 78:35-45.
54. Silver, R. F., Q. Li, W. H. Boom, and J. J. Ellner. 1998. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. J. Immunol. 160:2408-2417.
55. Skamene, E., E. Schurr, and P. Gros. 1998. Infection genomics: Nramp 1 as a major determinant of natural resistance to intracellular infections. Annu. Rev. Med. 49:275-287.
56. Stach, J. L., P. Gros, E. Skamene, and A. Forget. 1984. Phenotypic expression of genetically controlled natural resistance to Mycobactenum bovis (BCG). J. Immunol. 132:888-892.
57. Stead, W. W., J. W. Senner, W. T. Reddick, and J. P. Lofgren. 1990. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 322:422-427.
58. Underhill, D. M., A. Ozinsky, K. D. Smith, and A. Aderem. 1999. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96:14459-14462.